Loading stock data…
APYX
$4.72-0.14 (-2.78%)
Market OpenUpdated 3:00 PM EDT
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Apyx Medical Corporation in the Healthcare sector is trading at $4.72. Wall Street consensus targets $6.50 (4 analysts), implying a +37.6% move over the next 12 months. The stock is currently near its 52-week high of $4.99, remaining 36.2% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +37.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $12.49M↓ | $19.16M↑ | $12.88M↑ | $11.37M↑ | $9.43M |
| Gross Profit | $7.92M↓ | $12.00M↑ | $8.30M↑ | $7.08M↑ | $5.67M |
| Operating Income | -$911,000↓ | $11,000↑ | -$832,000↑ | -$2.57M↑ | -$3.05M |
| Net Income | -$2.11M↓ | -$1.30M↑ | -$1.98M↑ | -$3.78M↑ | -$4.15M |
Peer Comparison
JNJUNHPFE
Fundamentals
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-71.45%
Volume
Today's trading volume
86,026
Recent News
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals
Apyx Medical’s fair value target has been nudged to US$6.50 from US$6.40, a small move that still gives you a fresh reference point for thinking about the stock. This adjustment sits against a backdrop of mixed Street commentary, where bulls focus on 2026 guidance, new products and international expansion, while more cautious voices highlight execution risks and higher expectations. Read on to see how these shifting price targets fit into the broader story and what to watch as the narrative...
What to Know About This Fund's $13.9 Million Exit From a Skyrocketing AI Power Play
Babcock & Wilcox delivers energy and emissions control solutions to industrial and utility clients worldwide.
Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growth
Oceaneering International delivers subsea robotics, engineered products, and digital solutions to global energy and defense clients.
What to Know About This Fund's $9 Million Exit From a Pawn Shop Giant Up Nearly 150% This Past Year
EZCORP operates a broad network of pawn stores and digital platforms, serving consumers seeking short-term credit and value-priced goods.
This Satellite Company Grew Revenue 80%. One Fund Just Disclosed Buying $6 Million Worth of Shares
Satellogic delivers real-time Earth observation data and analytics, serving commercial and government clients across multiple industries.